ContiGroup Companies

Equity Group Investments: Investor Consortium Partners with Baja Aqua-Farms to Promote Future Growth

Retrieved on: 
Wednesday, November 29, 2023

Continental Grain Company (Conti), Organización Cultiba SAB de CV (Cultiba), Equity Group Investments (EGI), and Castle Harlan Inc. today announced an investment in Baja Aqua-Farms (the “Company”), a leading vertically integrated Bluefin tuna rancher based in Baja California, Mexico.

Key Points: 
  • Continental Grain Company (Conti), Organización Cultiba SAB de CV (Cultiba), Equity Group Investments (EGI), and Castle Harlan Inc. today announced an investment in Baja Aqua-Farms (the “Company”), a leading vertically integrated Bluefin tuna rancher based in Baja California, Mexico.
  • The Company’s fresh sashimi grade tuna is sought out by top chefs around the globe for its consistent quality and year-round availability.
  • Manuel Vazquez, Chief Executive Officer of Baja Aqua-Farms, commented: “We look forward to partnering with the investor consortium.
  • Their combined operational expertise will be a major asset in driving the growth and expansion of our business going forward.

Pivot Bio Names Chris Abbott CEO; Announces FY2023 Results and Expansion of U.S. Operations

Retrieved on: 
Tuesday, August 29, 2023

Chris has also served as a board director for several agriculture tech companies, including Pivot Bio since 2018.

Key Points: 
  • Chris has also served as a board director for several agriculture tech companies, including Pivot Bio since 2018.
  • “Chris has the skills, ag expertise, and strategic vision to scale Pivot Bio into its next stage of growth as it delivers solutions that growers trust for their crops,” said Pivot Bio Board Chairperson Roger Underwood .
  • “After conducting a thorough search, it was clear that Chris is perfectly suited to lead Pivot Bio moving forward.
  • “With our strong fiscal year 2023 results and expansion plans to meet farmers’ increasing demand, Pivot Bio is well-positioned for its next phase of growth under Chris’ leadership,” said Pivot Bio Co-founder and Chief Innovation Officer Karsten Temme .

Bushel® Secures $26 Million to Accelerate Digitization in Agriculture

Retrieved on: 
Tuesday, August 22, 2023

Bushel is an independently-owned software company that develops digital tools for farmers and agribusinesses in the agricultural supply chain.

Key Points: 
  • Bushel is an independently-owned software company that develops digital tools for farmers and agribusinesses in the agricultural supply chain.
  • Bushel’s software digitizes, permissions, and accelerates the flow of information, transactions, and payments through secure mobile and desktop applications.
  • “We appreciate the strong support of our investors, who recognize the value Bushel is bringing to agriculture,” Jake Joraanstad, Bushel CEO said.
  • Continued commitment to security: Bushel is SOC 2 Type II compliant, reaffirming its dedication to safeguarding confidential information and customer data in agriculture.

Phospholutions Raises $10.15M to Accelerate Commercialization of Higher Efficiency Fertilizers

Retrieved on: 
Tuesday, August 15, 2023

“We are pleased to welcome new investors like Advantage and Keytrade supporting our efforts to accelerate commercialization of our phosphate efficiency technology.

Key Points: 
  • “We are pleased to welcome new investors like Advantage and Keytrade supporting our efforts to accelerate commercialization of our phosphate efficiency technology.
  • Additionally, the continued support from our existing investors really fortifies what we are doing to bring new sustainable fertilizers to the U.S. farmer,” says Jason Burke, Vice President of Finance at Phospholutions .
  • Conventional phosphorus fertilizers exhibit low efficiency, with as little as 10% being utilized by the crop during the year of application.
  • To learn more about Phospholutions and follow their journey, visit www.phospholutions.com or on LinkedIn.

Sentera Announces Series C Funding Expansion

Retrieved on: 
Tuesday, May 2, 2023

ST. PAUL, Minn., May 2, 2023 /PRNewswire/ -- Sentera, an industry-leading provider of ag analytics, announced today a successful expansion of its previously oversubscribed Series C funding round. The round was led by Conti Ventures (a division of Continental Grain Company) and S2G Ventures. Following this round, Sentera forecasts that its capital requirements to achieve profitability and positive cash flow are fully funded.

Key Points: 
  • ST. PAUL, Minn., May 2, 2023 /PRNewswire/ -- Sentera , an industry-leading provider of ag analytics, announced today a successful expansion of its previously oversubscribed Series C funding round.
  • Following this round, Sentera forecasts that its capital requirements to achieve profitability and positive cash flow are fully funded.
  • "We believe Sentera has unlocked value for its enterprise customers and partners with differentiated technology illustrated by its accelerated growth and blue-chip customer list," said Chris Abbott, co-head, Conti Ventures.
  • "This opens up avenues for further expansion through strategic M&A, positioning the company as a customer-focused agronomic data platform."

Announcing the 45 Standout Startups Selected for FoodBytes! 2022

Retrieved on: 
Tuesday, October 25, 2022

NEW YORK, Oct. 25, 2022 /PRNewswire/ -- Today, FoodBytes!, Rabobank's global food and ag innovation discovery hub, announced the 45 companies that were selected to participate in this year's program. As a champion for cross-industry collaboration between the most promising startups, corporates and investors to drive greater sustainable solutions, FoodBytes! selected fifteen startups over three quarters based on different sector themes and criteria, including:

Key Points: 
  • now has a total alumni network of 400+ startups who have raised a total of $3.2 billion in capital.
  • has been able to establish hundreds of individual connections between the chosen startups and its members.
  • FoodBytes!
  • Find more information on each of the selected startups for FoodBytes!

Ukko Appoints Pharma Industry Leader Dr. Tim Garnett to Advisory Board

Retrieved on: 
Tuesday, September 13, 2022

TEL AVIV, Israel, Sept. 13, 2022 /PRNewswire/ -- Ukko, the biotechnology company designing new proteins to treat and manage food allergies, today announced the expansion of its advisory board with the appointment of Dr. Tim Garnett, former Chief Medical Officer of Eli Lilly. Dr. Garnett brings decades of experience, influence, and leadership in the drug development space and will lend his expertise to Ukko as it advances its food allergy therapeutic into clinical trials and commercialization.

Key Points: 
  • Ukko uses its AI-driven protein engineering platform to design measurably better and safer proteins for use in food and therapeutics.
  • "As Ukko progresses towards the clinical stage, we are thrilled to add Dr. Tim Garnett to our advisory board," said Anat Binur, co-founder and CEO of Ukko.
  • Ukko's advisory board supports the company on the policy, business strategy, science, and clinical aspects of Ukko's work.
  • Dr. Garnett joins several other advisory board members already in place .

AgTech and Genomics pioneer Pattern closes $35M funding round led by Conti Ventures

Retrieved on: 
Thursday, August 25, 2022

Patterns biological analytics service gives farmers actionable insight into the ways in which their soil biology impacts their on-farm outcomes.

Key Points: 
  • Patterns biological analytics service gives farmers actionable insight into the ways in which their soil biology impacts their on-farm outcomes.
  • Pattern provides predictive soil analytics that track pest, pathogen, biofertility, and nutrient levels for corn and soybean growers across the Midwest.
  • Pattern has enabled their customers to refine management decisions by providing actionable insights, and customizable recommendations on an intuitive platform.
  • Just as genomics technology is rapidly becoming the front-line diagnostic test in human health, Pattern is applying these same genomics techniques to understanding plant health.

GreenLight Biosciences announces $109 million financing

Retrieved on: 
Friday, August 12, 2022

We are also delighted to welcome new investors who have decided to join GreenLight in our mission to feed the world and keep it healthy.

Key Points: 
  • We are also delighted to welcome new investors who have decided to join GreenLight in our mission to feed the world and keep it healthy.
  • GreenLight intends to use the net proceeds from the financing to advance its development of research and commercial programs and for working capital and general corporate purposes.
  • GreenLight Biosciences (Nasdaq: GRNA) aims to address some of the worlds biggest problems by delivering on the full potential of RNA for human health and agriculture.
  • For additional information on GreenLight and potential risks associated with investing, please see our public filings at https://www.sec.gov/edgar/browse/?CIK=1822691&owner=exclude.

Phospholutions, Inc. Attracts Additional Capital from Global Ag Companies

Retrieved on: 
Wednesday, July 6, 2022

Phospholutions Inc. , a leader in sustainable fertilizer technology, has announced additional investment from leading global agricultural companies to support commercialization of RhizoSorb in the US row crop market.

Key Points: 
  • Phospholutions Inc. , a leader in sustainable fertilizer technology, has announced additional investment from leading global agricultural companies to support commercialization of RhizoSorb in the US row crop market.
  • At the time, the investments were led by Continental Grain Company with participation from Tekfen Ventures , Maumee Ventures , Ag Ventures Alliance , and 1855 Capital .
  • Radicle Growth selects innovative, early-stage companies for investment, ensuring that disruptive Agtech & Food Tech companies reach their full potential.
  • In addition to providing seed-stage capital, Radicle Growth provides a fertile environment for visionaries in agriculture and food space to flourish.